The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Comparison of Ketamine-Induced Thought Disorder in Healthy Volunteers and Thought Disorder in Schizophrenia
Abstract
OBJECTIVE: This study sought to determine whether thought disorder induced in healthy volunteers by the N-methyl-D-aspartic acid (NMDA) receptor antagonist ketamine resembles the thought disorder found in patients with schizophrenia. METHOD: The Scale for the Assessment of Thought, Language, and Communication was used to assess thought disorder in healthy volunteers (N = 10) who received subanesthetic doses of ketamine and in a group of clinically stable inpatients with schizophrenia (N = 15) who did not receive ketamine. RESULTS: Mean scores on the Scale for the Assessment of Thought, Language, and Communication for patients with schizophrenia and healthy volunteers receiving ketamine did not differ significantly. Moreover, three of the four highest rated test items in both groups were the same. CONCLUSIONS: These data suggest that ketamine-induced thought disorder in healthy volunteers is not dissimilar to the thought disorder in patients with schizophrenia and provide support for the involvement of the NMDA receptor in a cardinal symptom of schizophrenia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Brief Psychiatric Rating Scale.
Overall, J. E., & Gorham, D. R. (1962) · Psychological Reports · doi:10.2466/pr0.1962.10.3.799 · Cited by 11,090
Krystal, J. H. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950030035004 · Cited by 3,330
Subanesthetic Doses of Ketamine Stimulate Psychosis in Schizophrenia
Lahti, A. (1995) · Neuropsychopharmacology · doi:10.1016/0893-133x(94)00131-i · Cited by 921
Study of a New Schizophrenomimetic Drug—Sernyl
LUBY, E. D. (1959) · Archives of Neurology And Psychiatry · doi:10.1001/archneurpsyc.1959.02340150095011 · Cited by 921
NMDA Receptor Function and Human Cognition: The Effects of Ketamine in Healthy Volunteers
Malhotra, A. (1996) · Neuropsychopharmacology · doi:10.1016/0893-133x(95)00137-3 · Cited by 680
Self-citationMalhotra, M. D. (1997) · Neuropsychopharmacology · doi:10.1016/s0893-133x(97)00036-5 · Cited by 680
Scale for the Assessment of Thought, Language, and Communication (TLC)
Andreasen, N. C. (1986) · Schizophrenia Bulletin · doi:10.1093/schbul/12.3.473 · Cited by 367
Effects of Ketamine on Thought Disorder, Working Memory, and Semantic Memory in Healthy Volunteers
Adler, C., Goldberg, T., Malhotra, A., Pickar, D., & Breier, A. (1998) · Biological Psychiatry · doi:10.1016/s0006-3223(97)00556-8 · Cited by 304
Self-citation(3H]MK-801 binding sites in postmortem brain regions of schizophrenic patients
Kornhuber, J., Mack-Burkhardt, F., Riederer, P., Hebenstreit, G. F., Reynolds, G. P., Andrews, H. B., & Beckmann, H. (1989) · Journal of Neural Transmission · doi:10.1007/bf01248936 · Cited by 250
ASYMMETRICAL LOSS OF GLUTAMATE RECEPTOR SUBTYPE IN LEFT HIPPOCAMPUS IN SCHIZOPHRENIA
Kerwin, R. W., Patel, S., Meldrum, B. S., Czudek, C., & Reynolds, G. P. (1988) · The Lancet · doi:10.1016/s0140-6736(88)91371-2 · Cited by 177
The interaction of ketamine with the opiate receptor
Smith, D. J., Pekoe, G. M., Martin, L. L., & Coalgate, B. (1980) · Life Sciences · doi:10.1016/0024-3205(80)90285-4 · Cited by 161
Smith, D. J., Azzaro, A. J., Zaldivar, S. B., Palmer, S., & Lee, H. S. (1981) · Neuropharmacology · doi:10.1016/0028-3908(81)90015-0 · Cited by 90
Harvey, P. D., Lenzenweger, M. F., Keefe, R. S. E., Pogge, D. L., Serper, M. R., & Mohs, R. C. (1992) · Psychiatry Research · doi:10.1016/0165-1781(92)90048-8 · Cited by 72
Communicability and Thought Disorder in Schizophrenics and Other Diagnostic Groups
Ragin, A. B., & Oltmanns, T. F. (1987) · The British Journal of Psychiatry · doi:10.1192/bjp.150.4.494 · Cited by 64
Inhibition of mammalian brain acetylcholinesterase by ketamine
Cohen, M. L., Chan, S.-L., Bhargava, H. N., & Trevor, A. J. (1974) · Biochemical Pharmacology · doi:10.1016/0006-2952(74)90377-3 · Cited by 58
Chronic Schizophrenia‐Like States in Methamphetamine Psychosis
Tomiyama, G. (1990) · Psychiatry and Clinical Neurosciences · doi:10.1111/j.1440-1819.1990.tb01626.x · Cited by 47
Reduction of cerebrospinal fluid glutamic acid in huntington's chorea and in schizophrenic patients
Kim, J. S., Kornhuber, H. H., Holzm�ller, B., Schmid‐Burgk, W., Mergner, T., & Krzepinski, G. (1980) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/bf00365738 · Cited by 45
Noncompetitive N-methyl-D-aspartate antagonists affect multiple ionic currents.
Rothman, S. M. (1988) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)20992-2 · Cited by 43
Harvey, P. D., Davidson, M., WHITE, L. E., Keefe, R. S. E., Hirschowitz, J., Mohs, R. C., & Davis, K. L. (1996) · Biological Psychiatry · doi:10.1016/0006-3223(95)00486-6 · Cited by 35
Harvey, P. D., Lombardi, J., Leibman, M., Parrella, M., WHITE, L. E., Powchik, P., Mohs, R. C., Davidson, M., & Davis, K. L. (1997) · American Journal of Psychiatry · doi:10.1176/ajp.154.2.205 · Cited by 32
Behavioral effects of phencyclidine and ketamine alone and in combination with other drugs
Byrd, L. D., Standish, L. J., & Howell, L. L. (1987) · European Journal of Pharmacology · doi:10.1016/0014-2999(87)90386-4 · Cited by 31
Cuesta, M. J., & Peralta, V. (1993) · Schizophrenia Research · doi:10.1016/0920-9964(93)90050-s · Cited by 20
LSD: The Varieties of Psychotic Experience
Cohen, S. (1985) · Journal of Psychoactive Drugs · doi:10.1080/02791072.1985.10524333 · Cited by 19
A Comparative Study of Thought Disorder in Acute and Chronic Schizophrenia
Mazumdar, P. K., Chaturvedi, S. K., & Gopinath, P. S. (2010) · Psychopathology · doi:10.1159/000284921 · Cited by 7
Cited by
Homayoun, H., & Moghaddam, B. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.2213-07.2007 · Cited by 1,231
Glutamate and Schizophrenia: Beyond the Dopamine Hypothesis
Coyle, J. T. (2006) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-006-9062-8 · Cited by 917
“Adler et al. (1999) using similar methods found that ketamine induced a thought disorder similar to that observed in schizophrenia.”
ResultKetamine Pharmacology: An Update ( Pharmacodynamics and Molecular Aspects, Recent Findings )
Mion, G., & Villevieille, T. (2013) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12099 · Cited by 711
Automated analysis of free speech predicts psychosis onset in high-risk youths
Bedi, G., Carrillo, F., Cecchi, G. A., Slezak, D. F., Sigman, M., Mota, N. B., Ribeiro, S., Javitt, D. C., Copelli, M., & Corcoran, C. M. (2015) · npj Schizophrenia · doi:10.1038/npjschz.2015.30 · Cited by 673
Effects of Ketamine in Normal and Schizophrenic Volunteers
Lahti, A. (2001) · Neuropsychopharmacology · doi:10.1016/s0893-133x(01)00243-3 · Cited by 674
Metadata
- Authors
- Adler, C. M., Malhotra, A. K., Elman, I., Goldberg, T., Egan, M., Pickar, D., & Breier, A.
- Venue
- American Journal of Psychiatry
- Published
- 1999-10-01
- Volume
- 156
- Issue
- 10
- Pages
- 1646-1649
- ISSN
- 0002-953X (ISSN-L)
- 1535-7228
- OpenAlex
- W2071723486
- Cited by
- 337
- References
- 24
- FWCI
- 3.73
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.